Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Visual of a brain
Biotech

Roche ends 2 Huntington’s programs, including Ionis ASO

Both drugs are antisense oligonucleotides targeting the huntingtin gene, which causes Huntington’s when a mutation leads to its expansion over time.
Darren Incorvaia Jul 9, 2026 2:40pm
computer and clinical science AI data

Fate’s CAR-T prospect shows early promise in systemic sclerosis

Jul 9, 2026 10:24am
ArticlePrimaryImagejpg

Can We Outrun Cancer's Evolution? Why We Need a New Approach

Brought to you by BrYet US, Inc.
Exhibition Hall BIO

Biotech revenue plans ‘won’t look as sunny’ after Trump tax bill

Jul 9, 2026 9:28am
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
drawing of magnifying glass on a brain

GSK cuts losses on $700M upfront Alzheimer’s collab with Alector

Jul 9, 2026 7:30am